Abstract:Background Osteoporosis and sarcopenia are common age-related conditions characterized by the progressive loss of bone density and muscle mass, respectively. Their co-occurrence, often referred to as osteosarcopenia, presents significant challenges in elderly care due to increased fragility and functional impairment. Existing studies have identified shared pathological mechanisms between these conditions, including inflammation, hormonal imbalances, and metabolic dysregulation, but a comprehensive understanding of their molecular interplay remains incomplete. Objective This study aims to deepen our understanding of the molecular interactions between sarcopenia and osteoporosis through an integrated omics approach, revealing potential therapeutic targets and biomarkers. Methods Employing a combination of proteomics and transcriptomics analyses, this study analyzed bone and muscle tissue samples from patients diagnosed with osteoporosis and osteosarcopenia. Techniques included high-throughput sequencing and label-free proteomics, supported by advanced bioinformatics tools for data analysis and functional annotation of genes and proteins. Results The study found marked differences in gene and protein expressions between osteoporosis and osteosarcopenia tissues. Specifically, genes like PDIA5, TUBB1, and CYFIP2 in bone, along with MYH7 and NCAM1 in muscle, exhibited differential expression at both mRNA and protein levels. Pathway analyses revealed the significance of oxidative-reduction balance, cellular metabolism, and immune response in the progression of these conditions. Importantly, the study pinpointed osteoclast differentiation and NF-kappa B signaling pathways as critical in the molecular dynamics of osteosarcopenia, suggesting potential targets for therapy. Conclusions This study utilized transcriptomics and proteomics to identify key genes and proteins impacting sarcopenia and osteoporosis, employing advanced network tools to delineate interaction networks and crucial signaling pathways. It highlighted genes like PDIA5 and TUBB1, consistently expressed in both analyses, involved in pathways such as osteoclast differentiation and cytokine interactions. These insights enhance understanding of the molecular interplay in bone and muscle degeneration with aging, suggesting directions for future research into therapeutic interventions and prevention strategies for age-related degenerative diseases.

Bone and Muscle Crosstalk in Aging

Muscle-Bone Crosstalk And Potential Therapies For Sarco-Osteoporosis

Aging, Osteo-Sarcopenia, and Musculoskeletal Mechano-Transduction

Bidirectional crosstalk between bone and muscle: the role of RANKL pathway in osteosarcopenia

Determinants of Muscle and Bone Aging

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

Integrating Transcriptomic and Proteomic Data for a Comprehensive Molecular Perspective on the Association between Sarcopenia and Osteoporosis

Targeting Crosstalk of Signaling Pathways among Muscles-Bone-Adipose Tissue: A Promising Therapeutic Approach for Sarcopenia

Role of Physical Activity in Bone–Muscle Crosstalk: Biological Aspects and Clinical Implications

Association of Sarcopenia with Osteoporosis: Research and Application

Muscle-Bone Crosstalk in Chronic Obstructive Pulmonary Disease

Molecular and Cellular Aspects of Sarcopenia, Muscle Healthy Aging and Physical Conditioning in the Elderly

Recent advances in cell-based and cell-free therapeutic approaches for sarcopenia

Exercise to Mend Aged-tissue Crosstalk in Bone Targeting Osteoporosis & Osteoarthritis

Crosstalk between bone and muscle in chronic kidney disease

An Integrated Approach to Skeletal Muscle Health in Aging

Osteoporosis and sarcopenia: two diseases or one?

Deciphering Immune Landscape Remodeling Unravels the Underlying Mechanism for Synchronized Muscle and Bone Aging

Targeting Aging with the Healthy Skeletal System: the Endocrine Role of Bone

Muscle aging and sarcopenia: The pathology, etiology, and most promising therapeutic targets

Sarcopenic obesity and osteoporosis: Research progress and hot spots